FDA Inspection 1203313 — Enem Nostrum Remedies Pvt. Ltd
The FDA completed an inspection of Enem Nostrum Remedies Pvt. Ltd on Feb 17, 2023 in Mumbai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 17, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mumbai (India)
Additional Details
Bioanalytical BA/BE